Skip to main content

Home/ Aging report/ Group items tagged aging

Rss Feed Group items tagged

Danila Medvedev

Alliance for Aging Research: Resources - 0 views

  • Diseases & Conditions
  • Diseases & Conditions
    • Danila Medvedev
       
      Разные организации (фонды и ассоциации) по отдельным болезням могут привлечь огромные ресурсы,если убедить их в том, что борьба со старением в целом в их интересах.
  • American Federation for Aging Research American Foundation for Aging Research
  • ...14 more annotations...
  • AGS Foundation for Health in Aging
  • American Geriatrics Society
  • American Society on Aging
  • The Centenarian
  • ConsultGeriRN
  • Foundation Aiding the Elderly (F.A.T.E.)
  • Gerontological Society of America (GSA)
  • Huffington Center on Aging/ Baylor College of Medicine
  • International Association of Gerontology
  • International Council on Active Aging
  • International Longevity Center (ILC)
  • Leadership Council of Aging Organizations
  • Health & Aging Agencies/Institutes Buck Institute Cancer Research Institute Institute for Advanced Studies in Aging & Geriatric Medicine National Council on the Aging National Heart, Lung and Blood Institute National Institute of Arthritis and Musculoskeletal and Skin Disease (NIAMS) National Institute of Diabetes & Digestive and Kidney Diseases National Institute of Health (NIH) National Institute of Mental Health (NIMH) National Institute on Aging Senate Special Committee on Aging Senior Citizens' Resources United States EPA Aging Initiative U.S. Administration on Aging Women's Research & Education Institute
  • National Council on Aging
  •  
    Различные организации, имеющие отношение к старению
Danila Medvedev

Pharmaceuticals and Aging - Interview with Dr. Larry Miller (SAGE CROSSROADS ) - 0 views

  • Dr. Miller formerly led business operations for the global Drug Discovery Division at pharmaceutical company Glaxo Smith Kline.
  • Well one thing that I think is going to be critical is that in the past, pharmaceutical companies had treated diseases of aging as discrete entities, that is to develop something for diabetes, to develop something for osteoporosis…that is to treat each one as a separate silo if you will.
  • in the future we are going to have to look at more central regulatory pathways that are being identified now for aging.
  • ...15 more annotations...
  • I think this is quite a new concept because not until recently have we begun to understand a little bit more about the aging process and find some biochemical pathways that are at the root of aging processes.
  • Now what do you see as the greatest challenges for developing drugs that deal with aging? Would you say that it’s more regulatory and policy wise, or is this more scientific?
  • I think there is both.
  • When I was heading aging at Glaxo Smith Kline, the issues that I faced were that I was very interested in developing medications for frailty and weakness in muscle for when people get old because when people get weak they usually stop eating and then they fall and break a hip and end up in the hospital and die potentially, but the regulatory apparatus isn’t there yet.
  • Sarcopenia isn’t recognized as an official disease by the FDA, so the pathway to get drugs approved for frailty and to get more people mobile and into society is just not there, and so it’s a really difficult problem, and the pathways for osteoporosis are still very cumbersome, requiring fracture analysis.
  • There isn’t an approved, for example, like Jack Coralnick uses a scale at NIH to test people’s function. I think there is a critical need to have the FDA to recognize some battery of functional tests
  • how a reform would take place
  • Well we have a new FDA now, hopefully, but it’s going to take companies and scientists going to the FDA and to Congress to say “look the patient population is aging and currently we have a bottleneck, we can’t get these medicines through” and try to work out some new policy. Hopefully, the FDA will be a little more progressive about looking at endpoints. They are very, very conservative about what endpoints they will accept
  • You know, there is understandably some concern that people might use these drugs and abuse them for muscle building, but on the other hand, there is a critical unmet need out there in the elderly population
  • Well one thing is that it is quite difficult and expensive to develop drugs for aging per se because even to do pre-clinical models in animals is very expensive. It’s very expensive to get aged animals, and they don’t necessarily act like aged humans. So even in the pre-clinical stage, it’s a difficult area to work in.
  • find pathways to get these drugs approved
  • a lot of these companies are concerned as being seen as trying to produce “fountain of youth” drugs. I made it very clear when I was leading aging at GSK that I was not attempting simply to extend lifespan
  • I think this is a policy challenge and a perceptual challenge and if you will, a public relations challenge.
  • Potentially, I think we need to find more intelligent, creative ways to do clinical trials using biomarkers or other types of measures where we can get the trials through quickly
  • again, it goes back to the FDA policy. The FDA is going to have to be willing to accept some of these things, or we will not be able to get these drugs on the market
  •  
    Фармацевтика и старения (лекарства от старости)
Danila Medvedev

Department of Health and Ageing - Australian Government's response to population ageing - 0 views

  • In responding to population ageing, the Australian Government takes a whole-of-government perspective across superannuation and retirement income support, workforce, housing, social inclusion and life long education, as well as medical, health and aged care services
    • Danila Medvedev
       
      Но, как это типично для всех правительств, ничего не делается для борьбы со старением.
  •  
    Нам нужен не только раздел "Политика", но и "Policy"! Особенно, в контексте планируемого раздела по лоббированию. Можно сказать, что нужны три раздела - описывающий проблему (демография, этика и т. п.), описывающий политику (игроки, отношение общества и т. п.), а также описывающий существующие и возможные решения, т. е. policy.
Danila Medvedev

Practical Ethics: Why We Need a War on Aging - 0 views

  • Anti-aging research is scandalously under-funded.  In the US, a vast proportion of the funding doled out by the National Institute of Aging is given to research on Alzheimer's disease. According to one estimate (from circa 2004), only about 0.02% of the money spent by the National Institutes of Health (of which the NIA is part) is spent on fundamental aging research.
    • Danila Medvedev
       
      Финансирование фунд. исследований (непонятно, чья оценка)
  • The more we understand about the biochemical processes involved in senescence the more we find that they look like disease processes. The accumulation of lysosomal aggregates and amyloid plaques, extracellular protein-protein cross-linking, nuclear and mitochondrial mutations, cell atrophy, cell senescence, and cell loss without replacement: these processes may all be implicated in both pathology and senescence.   At the level of genetics and biochemistry, there simply does not seem to be any meaningful distinction between "processes predisposing to or constituting disease" and "normal aging".
    • Danila Medvedev
       
      Современное понимание
  • Aging is not an evolutionary adaptation. Aging, rather, is what happens when various bodily systems evolved to maintain health gradually accumulate defects and begin to malfunction. In the Pleistocene, when life-expectancy is estimated to have been a mere 20 years, too few of our ancestors survived to ripe old age for evolution to favor investment in stronger anti-aging defenses than those we now possess and are forced to rely upon, notwithstanding their evident inadequacy in the modern era where many causes of premature death have been removed.
    • Danila Medvedev
       
      Современное понимание
Danila Medvedev

Alliance for Aging Research: Coalitions - 0 views

  • Friends of the National Institute on Aging (FoNIA) The Friends of the NIA (FONIA) is a broad-based coalition of more than 45 aging, disease, research, and patient groups committed to the advancement of medical research that affects millions of older Americans. FONIA was founded to support the research and training mission of the National Institute on Aging (NIA) and to effectively address current and future challenges in aging research.
  • Leadership Council of Aging Organizations The LCAO is a large coalition of the nation's non-profit organizations serving older Americans. The 53 member association is diverse and dedicated to preserving and strengthening the well-being of America's older population, providing a voice for seniors and their families in the ongoing national debate on aging policy.
  • National Coalition on Mental Health & Aging The National Coalition on Mental Health & Aging provides opportunities for professional, consumer, and government organizations to work together towards improving the availability and quality of mental health preventive and treatment strategies to older Americans and their families through education, research, and increased public awareness.
  •  
    Примеры медицинских коалиций. Надо это знать и отталкиваться от этого, создавая нашу коалицию!!!
Danila Medvedev

Aging Research Network-Rationale - 0 views

  • There are two aspects to aging which most will recognize, the chronological passage of time which we associate with the benefits of increased experience and wisdom, and the increasing levels of dysfunction we experience as we get older.  One is welcome, the other less so.
  • It is estimated that 80% of our health care dollars go to the treatment of age-related dysfunction.  The Miliken Institute reported in Oct 2007 that in 2003 it cost 1.3 TRILLION DOLLARS per year in direct and indirect costs ameliorate the suffering of the aged. This is in stark contrast to the 150-200 Million Dollars actualy spent on studying aging which amounts to 1/6th of 1 percent of the yearly budget of the National Health Institute of 28 Billion dollars.
    • Danila Medvedev
       
      это в финансирование
  • The reason for this disproportionate focus on spending on dysfunction instead of research is that aside from healthy lifestyle choices, little can presently be done to intervene in the aging process and people tend to disbelieve that serious progress will ever be made in addressing the dysfunction that accompanies the aging process.  Due to new breakthroughs this overly-pessimistic perspective is slowly changing.
    • Danila Medvedev
       
      наверное в научные возможности вмешательства
  • ...1 more annotation...
  • The chart to the right describes the aging process from the point of view of increasing dysfunction and the different ways in which medicine and science try to deal with it
    • Danila Medvedev
       
      часть нашей схемы. идет в современное понимание старения.
  •  
    в современное понимание старения. есть небольшая схема, которая интегрируется с моей схемой про смерть.
Danila Medvedev

Alliance for Aging Research: Publications: 2007 Task Force Report on Aging Research Fun... - 1 views

  • 2007 Task Force Report on Aging Research Funding
  • Download - Adobe Acrobat (PDF), 1.37 MB
  • The 2007 Task Force on Aging Research Funding--more than 85 non-partisan disease groups, patient advocates, and foundations--urges Congress and the President to chart a better course for medical research on behalf of America's aging population. This year's report of the Task Force calls for a 6.7% increase in funding for the National Institutes of Health in FY 2008. It also presents data on the burden of 27 diseases and conditions that predominately affect older Americans, highlights some of the exciting work the NIH is doing to decrease these burdens, and serves as a resource for policymakers working to establish the funding levels necessary to advance healthy aging.
  •  
    Оч. релевантный документ. Надо изучить. Касается Соединённых Штатов.
Danila Medvedev

Alliance for Aging Research: Events: Going for the Longevity Dividend - 0 views

  • A Capitol Hill Symposium & Luncheon September 12, 2006 Hart Senate Office Building, #902 At this international gathering organized by the Alliance for Aging Research, prominent scientists called for governments and health care organizations worldwide to invest in the extension of healthy human life in order to produce a "Longevity Dividend" for nations with aging populations.
  • Read the statement released by the group of more than 90 scientists.
  • III. International Perspectives Alex Kalache, Director, Ageing and Health Program, World Health Organization (WHO) - SLIDES James Goodwin, PhD, Head of Research, Help the Aged, London, England - SLIDES
  • ...2 more annotations...
  • IV. View to the Future Dr. Alan Leshner, CEO, American Association for the Advancement of Science (AAAS)
  • I. How Soon Before Science Can Slow Aging and at What Cost? Opening Remarks from: Senator Larry Craig (R-ID), S. Jay Olshansky, PhD, University of Illinois at Chicago - SLIDES Leonard Guarante, PhD, Massachusetts Institute of Technology - SLIDES
  •  
    В 1970-е годы (когда основывали Национальный институт старения) осознали (в Конгрессе): многие болезни, изучение которых тогда щедро финансировали (рак, сердечно-сосудистые), связаны со старением населения. Поэтому, если лучше изучить старение, возможно, будет легче справиться и с этими болезнями (2:38 в видео).
  •  
    4:10 - Veteran's Affairs Committee во многом стоял за развитием (и финансированием) гериатрии в США.
Danila Medvedev

Nathan W. Shock Lecture - 0 views

  • It was Dr. Shock's insistence on answering what he considered the discipline's two critical questions that made an impact on the field of gerontology: "What are the underlying biological factors that produce what we perceive as aging?" and, "What are the mechanisms that produce impaired performance with age?" For aging, he insisted, was not a disease.
    • Danila Medvedev
       
      Основатель NIA сказал, что старение - это НЕ заболевание. Он даже настаивал.
  • Nathan Wetherell Shock, Ph.D. began his gerontology career in 1941 as the chief of the newly formed Unit on Gerontology of the Division of Physiology of the five-year-old National Institute of Health. He took this two-man aging unit and built it into the internationally respected Gerontology Research Center of the National Institute on Aging, NIH. Dr. Shock was the catalyst for the emergence of aging research in the United States and overseas for nearly half a century.
    • Danila Medvedev
       
      в историю
Danila Medvedev

Anti-Aging Las Vegas - 0 views

  • Financing Anti-Aging Research
    • Danila Medvedev
       
      Пленарное заседание по финансированию исследований против старения. Много интересных презентаций. Надо бы их как-то заполучить, либо через докладчиков, либо через организаторов конференции, либо на сайте (поискать) конференции.
  • Project LIFE: A Comprehensive Global Approach to Anti-Aging Funding & Research
  • Financing Anti-Aging Research with Biotech
  • ...2 more annotations...
  • NIA Support for Anti-Aging Research
  • Panel Discussion: Creating Ways to Fund Anti-Aging Research
  •  
    Очень интересная пленарная сессия на конференции по антиэйджингу в 2004 году.
Danila Medvedev

Is Asia Prepared for an Aging Population? - 0 views

  • Many Asian countries (such as China, Singapore, Korea, Thailand, Malaysia, Indonesia, India, and the Philippines) will experience a significant aging of their populations during the next several decades. This paper explores how these aging Asian countries are addressing and anticipating the challenges of an aging society. It suggests that Asia's preparedness for an aging population is decidedly mixed. While growth policies have been successful, much work is still needed in many countries to establish an adequate and farsighted policy framework in the areas of pensions, health insurance, and labor market policies.
    • Danila Medvedev
       
      Рассматриваются азиатские страны (кроме Японии). Описываются (см. раздел Final Considerations) основные проблемы и прогнозы. Из перечисленных стран наибольшее внимание к проблемам старения уделяется в Сингапуре (в не включённой в данный обзор Японии тоже большое внимание).
Danila Medvedev

Alliance for Aging Research: Publications: Redesigning Healthcare for an Aging Nation: ... - 0 views

  • transcripts of a Congressional forum on March 17, 2003
  • With the impending age boom in 2010, our nation must have a healthcare system in place that is prepared for the millions of Americans who will be living with chronic diseases, and that is able to foster the development of future treatments to meet their needs.
  • Download - Adobe Acrobat (PDF), 1.64 MB
valerija

KLRI: Special Reports - 0 views

  • KLRI's State of the Science report is produced annually and chronicles KLRI's research as well as other promising research studies in the field of aging. The report gives an update on the critical areas of aging research and the importance of aging research in our society. Click on the links below to view the 2007 and 2008 State of the Science reports. Gray is the New Gold: Longevity Science Slowing the Spiral of Aging Gray is the New Gold: Longevity Science and the Flourishing Aging Society
    • valerija
       
      Обзор исследований в области старения. Ежегодный. Круто. Использовать
  •  
    Ежегодные обзоры состояния дел именно в науке о старении.
Danila Medvedev

The Problem, Illustrated - 0 views

  • 'Curing aging is not an endpoint the federal drug agency would recognize,' Dr. Westphal says dryly. Instead, both men say, they are working to ameliorate the diseases of aging." For so long as unelected government employees can declare, with no accountability and full force of law, what medicine is permitted and what is not, there will be no direct venture funded efforts to cure aging - or even to take the first steps by aiming to repair specific, identified age-related damage in order to intervene in the aging process. There is no lack of companies, research groups and billions of dollars ready to be directed to that end, as any brief survey of the biotechnology marketplace will show you - but the ignorant few who write policy continue to bury all that potential.
    • Danila Medvedev
       
      Пока FDA не рассматривает старение как болезнь, для которой можно разрабатывать и утверждать лекарства (а не утверждённые доктора не смогут прописывать, они вообще запрещены), бизнес не будет финансировать разработку средств лечения старения.
Danila Medvedev

National Institute on Aging - Normal Human Aging: The Baltimore Longitudinal Study of A... - 0 views

  • Normal Human Aging The Baltimore Longitudinal Study of Aging
    • Danila Medvedev
       
      Возможно, исследование, заложившее опасное и вредное представление о существовании "нормального старения" - т.е. старения со снижением функции (и повышением риска патологии), но не обязательно с заболеванием (не у всех и не сразу).
Danila Medvedev

National Institute on Aging - Wikipedia, the free encyclopedia - 0 views

  • The National Institute on Aging (NIA) is a division of the U.S. National Institutes of Health (NIH), located in Bethesda, Maryland. The NIA leads a broad scientific effort to understand the nature of aging and to extend the healthy, active years of life. In 1974, Congress granted authority to form NIA to provide leadership in aging research, training, health information dissemination, and other programs relevant to aging and older people. Subsequent amendments to this legislation designated the NIA as the primary Federal agency on Alzheimer's disease research.
Danila Medvedev

Maximum Life Foundation - Aging Research Foundation for Life Extension and Longevity - 0 views

  •  
    Какой-то проект.
valerija

KLRI: Media Coverage - 0 views

  • A mini review on KLRI's annual fundraiser, Enlightened Age Forum. Lighting the Path to Healthy Aging, Frontdoors, December 2007
    • valerija
       
      Финансирование в Kronos'е
  • A preview of KLRI's annual fundraiser, Enlightened Age Forum. Kronos Forum Will Feature Carmona, Arizona Repubic, September 29, 2007
    • valerija
       
      финансирование
  • A Q&A format profile of KLRI. Plan a Long, Healthy Life, Frontdoors, April 2007
    • valerija
       
      разная информация
  • ...1 more annotation...
  • A report on current trends in healthy aging and its benefits. Old and Improved: Over the Hill Isn't All Downhill, Arizona Republic, December 28, 2006
    • valerija
       
      ещё информация
Danila Medvedev

Population Aging is Accelerating | Stanford Center on Longevity - 0 views

  • Population Aging is Accelerating Age mix varies by region. In the more developed countries of the world, the number of old people will steadily increase, and the number of children will decline (Exhibit 4). By 2015, old people will outnumber children; this has already occurred in several countries, including Japan and Germany. By 2010, the working-age population will begin shrinking; by 2035, total population will begin shrinking.
    • Danila Medvedev
       
      Базовые цифры, графики и тренды по старению населения.
Danila Medvedev

Policy Challenges of Population Aging in Ireland - 0 views

  • The projected rise in age-related government spending as a share of GDP in Ireland over the next forty years is among the highest in the euro area. In the absence of reforms, public debt will increase to unsustainable levels. This paper uses the IMF's Global Fiscal Model to compare the macroeconomic effects of different fiscal strategies to accommodate the rise in age-related spending. The simulations suggest that adopting a package of measures, including an increase in the retirement age, broadening the tax base, and raising indirect taxes, would be a more growth-friendly strategy than relying exclusively on raising the social security contribution rate.
    • Danila Medvedev
       
      Ирландия. Экономика старения.
1 - 20 of 77 Next › Last »
Showing 20 items per page